699 results found

Mylan Pharmaceuticals Inc. and others ("Mylan") appealed from the District Court's grant of summary judgment that claim 8 of U.S. Patent 8,552,025 owned by Valeant Pharm.

James Love wrote an article entitled "Patent Strategy and The Internet of Medical Things," featured in Med Device Online.

Personalized medicine is especially intriguing, as a problem with most drugs are the potential side effects. From a naive perspective, administering drugs may appear...

Artificial Intelligence (AI) is a loaded technology buzzword that comes in different forms in various commercial products.

In mid-November 2018, Amazon grabbed headlines when it announced it will build part of its new headquarters in Northern Virginia.

In a non-precedential decision issued by the U.S. Court of Appeals for the Federal Circuit (FWP IP APS v. Biogen MA, Inc., October 24, 2018 ...

Clinical trials are a critical part of the development and approval process for drugs, biologics, and medical devices. The lengthy and public nature of clinical trials, however, can create challenges...

The district court's decision arouse out of a motion for judgment on the pleadings filed by Creative.

The Court of Appeals for the Federal Circuit (CAFC), on May 2, 2023, reversed the Delaware District Court's decision in HIP, Inc. v. Hormel Foods Corp., that David Howard of Unitherm should be added as a joint inventor on US 9,980,498, a patent owned by Hormel and directed to methods of precooking bacon and meat pieces.

CAFC, on May 2, 2023, reversed the Delaware District Court's decision in HIP, Inc. v. Hormel Foods Corp., that David Howard of Unitherm should be added as a joint inventor on US 9,980,498 (herein, the ‘498 patent), …

Plaintiff Zyrcuits IP LLC has sued Defendants Acuity Brands, Inc. and Universal Electronics Inc. for infringement of claim 4 of U.S. Patent No. 6,671,307 (the ‘307 patent).

On June 17, 2020, Hyper Ice, Inc. of Irvine, California ("Hyper Ice") filed a complaint (part 1, part 2, and part 3) requesting that the ITC commence an investigation pursuant to Section 337

In Intellectual Pixels Limited v. Sony Interactive Entertainment LLC, the Federal Circuit affirmed a Patent Trial and Appeal Board decision holding claims 1-12 of U.S. Patent No. 10,681,109 unpatentable as obvious.

I recently wrote an article (NHK-Fintiv Rule Challenges Look Futile at Federal Circuit) about a Federal Circuit decision that dismissed Mylan's appeal of a PTAB decision...

The Patent Trial and Appeals Board denied U.S. Well Services, LLC's (the Patent Owner) Motion to Amend the claims of U.S. Patent No. 10,254,732 B2 (the ‘732 Patent) during inter partes review...

Congress sought to keep Patent Office delays from prejudicing a patentee by granting PTA to compensate for the Patent Office delays.

Since the Federal Circuit's decision in Wyeth v. Kappos, 591 F.3d 1364, 93 U.S.P.Q. 2d 1257 (Fed. Cir. 2010), aff'g, Wyeth v. Dudas, 580 F. Supp. 2d 138, 88 U.S.P.Q.2d 1538 (D.D.C. 2008), which held that the USPTO was ...